NCT05557175Completed
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
A Mixed-methods Evaluation of the Clinical and Cost-effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
Source: ClinicalTrials.gov · Last updated 3 May 2024
Brief summary (registry, in English)
Neurogenic overactive bladder (NOAB) presents with urgency incontinence. Existing NOAB management is expensive, lacks standardized regimens, or is invasive. Therefore, evaluating the effectiveness of non-invasive repetitive transcranial magnetic stimulation (rTMS) for NOAB management among stroke survivors remains crucial. Objectives: Evaluate the effects of active-rTMS compared to sham-rTMS among stroke survivors with NOAB, the interventions' cost-effectiveness and explore their experiences qualitatively.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 25 Sept 2022
- Start date
- 9 Nov 2022
- Primary completion date
- 10 Jan 2024
- Lead sponsor
- The Hong Kong Polytechnic University
- Diseases
- Stroke
- NCT number
- NCT05557175
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 9 Nov 2022 to the primary completion date, 10 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of metals in the cranium, intracardiac lines, increased intracranial pressure, heart diseases, or cardiac pacemaker, use of sacral neuro-modulation
- Patients with a family history of epilepsy or seizures
- Participation in any other research project related to urinary incontinence; contra-indicated to MRI, urologic cancer, prostatic pathology, severe pelvic pain, six weeks post-surgery and non-neurogenic bladder
Other
- Pregnancy or less than six months postpartum stage
- Patients taking tricyclic antidepressants or neuroepileptics
Who the study is looking for
- Stroke survivors aged between 18-80 years diagnosed with NOAB
- Urodynamic findings confirming detrusor overactivity
- Experience moderate (OABSS scores: 6-11 points) to severe NOAB (OABSS scores: 12 points and above)
- Obtain a Mini-Mental State Examination (MMSE) score of ≥ 24
- Be willing to be randomized
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Hong Kong Polytechnic University Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.